Keywords
antihypertensive agent; piperazine derivative; urapidil; drug effect; drug monitoring; heart rate; hemodynamics; human; hypertension; intravenous drug administration; pathophysiology; randomized controlled trial (topic); review; risk factor; secondary prevention; Antihypertensive Agents; Drug Monitoring; Heart Rate; Hemodynamics; Humans; Hypertension; Injections, Intravenous; Piperazines; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention